J. Verhoef

2.0k total citations
42 papers, 1.5k citations indexed

About

J. Verhoef is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, J. Verhoef has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Molecular Medicine and 8 papers in Infectious Diseases. Recurrent topics in J. Verhoef's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). J. Verhoef is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). J. Verhoef collaborates with scholars based in Netherlands, United States and Germany. J. Verhoef's co-authors include Thomas J. Anchordoquy, Huub Schellekens, John F. Carpenter, Ad C. Fluit, M. Rozenberg-Arska, Judith Branger, Raymond M. Schiffelers, Marcel H.A.M. Fens, F.-J. Schmitz and Gert Storm and has published in prestigious journals such as Blood, Biomaterials and Clinical Infectious Diseases.

In The Last Decade

J. Verhoef

40 papers receiving 1.5k citations

Peers

J. Verhoef
Robert Cozens Switzerland
Li Yang China
Valerie A. Schroeder United States
Jung Hwa Lee South Korea
Anita R. Mistry United Kingdom
Neeraj Chauhan United States
M.E.M. Cruz Portugal
Bei Jia China
Krystyna Konopka United States
Yan Bao China
Robert Cozens Switzerland
J. Verhoef
Citations per year, relative to J. Verhoef J. Verhoef (= 1×) peers Robert Cozens

Countries citing papers authored by J. Verhoef

Since Specialization
Citations

This map shows the geographic impact of J. Verhoef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Verhoef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Verhoef more than expected).

Fields of papers citing papers by J. Verhoef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Verhoef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Verhoef. The network helps show where J. Verhoef may publish in the future.

Co-authorship network of co-authors of J. Verhoef

This figure shows the co-authorship network connecting the top 25 collaborators of J. Verhoef. A scholar is included among the top collaborators of J. Verhoef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Verhoef. J. Verhoef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sentí, Mariona Estapé, J. Verhoef, János Szebeni, et al.. (2021). Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement. Journal of Controlled Release. 341. 475–486. 124 indexed citations
2.
Verhoef, J., Arjan D. Barendrecht, Katrin F. Nickel, et al.. (2017). Polyphosphate nanoparticles on the platelet surface trigger contact system activation. Blood. 129(12). 1707–1717. 123 indexed citations
3.
Barendrecht, Arjan D., et al.. (2017). Live-cell Imaging of Platelet Degranulation and Secretion Under Flow. Journal of Visualized Experiments. 9 indexed citations
4.
Alaarg, Amr, et al.. (2016). Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment. International Journal of Nanomedicine. Volume 11. 5027–5040. 39 indexed citations
5.
Verhoef, J., et al.. (2016). A novel oral iron-complex formulation: Encapsulation of hemin in polymeric micelles and its in vitro absorption. European Journal of Pharmaceutics and Biopharmaceutics. 108. 226–234. 21 indexed citations
6.
Verhoef, J., John F. Carpenter, Thomas J. Anchordoquy, & Huub Schellekens. (2014). Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. Drug Discovery Today. 19(12). 1945–1952. 213 indexed citations
7.
Verhoef, J. & Thomas J. Anchordoquy. (2013). Questioning the use of PEGylation for drug delivery. Drug Delivery and Translational Research. 3(6). 499–503. 276 indexed citations
8.
Verhoef, J., et al.. (1999). Surveillance of resistance against antimicrobial agents. International Journal of Antimicrobial Agents. 12(2). 77–79. 5 indexed citations
9.
Schmitz, F.-J., Ad C. Fluit, B. Hofmann, et al.. (1998). The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 42(6). 807–810. 141 indexed citations
10.
Torensma, Ruurd, Ad C. Fluit, & J. Verhoef. (1994). Reactivity of Monoclonal Antibodies to Pseudomonas aeruginosa Isolates from Hospitalized Adults and Patients with Cystic Fibrosis. Clinical Infectious Diseases. 19(1). 11–14. 2 indexed citations
11.
Hoepelman, Andy I. M., et al.. (1993). A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections. Journal of Antimicrobial Chemotherapy. 31(suppl E). 147–152. 32 indexed citations
13.
Nicolle, Lindsay E., et al.. (1993). Comparison of Three Days’ Therapy with Cefcanel or Amoxicillin for the Treatment of Acute Uncomplicated Urinary Tract Infection. Scandinavian Journal of Infectious Diseases. 25(5). 631–637. 19 indexed citations
14.
Kooij, R. J. van, et al.. (1991). Influence of polymorphonuclear granulocytes on the zona-free hamster oocyte assay. Human Reproduction. 6(8). 1104–1107. 22 indexed citations
15.
Verhoef, J. & Ruurd Torensma. (1990). Prospects for monoclonal antibodies in the diagnosis and treatment of bacterial infections. European Journal of Clinical Microbiology & Infectious Diseases. 9(4). 247–250. 1 indexed citations
16.
Rademaker, Carin M. A., et al.. (1989). Pharmacokinetics of a single dose of ofloxacin in healthy elderly subjects using noncompartmental and compartmental models. Pharmacy World & Science. 11(6). 224–228. 8 indexed citations
17.
Kovarik, John M., I. M. Hoepelman, & J. Verhoef. (1989). Once-daily aminoglycoside administration: New strategies for an old drug. European Journal of Clinical Microbiology & Infectious Diseases. 8(9). 761–769. 43 indexed citations
18.
Velde, Egbert R. te, et al.. (1987). Antibody and Complement-Binding Activity of Viable and Nonviable Human Spermatozoa. Archives of Andrology. 18(3). 189–197. 10 indexed citations
19.
Oe, P. L., et al.. (1973). Pharmacokinetics of the New Penicillins. Chemotherapy. 19(5). 279–288. 10 indexed citations
20.
Verhoef, J., et al.. (1973). The Clearance of Antibiotics by the Artificial Kidney. Chemotherapy. 19(5). 272–278. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026